Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Apr;72(4):537-43.

Two opposing modes of action of beta-endorphin on lymphocyte function

Affiliations

Two opposing modes of action of beta-endorphin on lymphocyte function

P van den Bergh et al. Immunology. 1991 Apr.

Abstract

Five opioid peptides (alpha-, beta-, and gamma-endorphin, methionine- and leucine-enkephalin) were tested for their effect on the concanavalin A-induced proliferative response of splenocytes of adult male F344 rats. The continuous presence of these opioid peptides during culture of T cells did not affect proliferation. However, 30 min of preincubation with beta-endorphin (beta-end), but not with the other opioid peptides, resulted in a dose-dependent enhancement of proliferation of 50-100%. This potentiating effect of beta-end on proliferation was preceded by an increase in the production of interleukin-2 (IL-2) and in the extent of IL-2 receptor expression. The stimulatory effect of beta-end was not prevented by naloxone, indicating that classical opioid receptors were not involved. The continuous presence of beta-end (or alpha-end) in cultures of cells that had been preincubated with beta-end completely abolished the stimulatory effect, pointing towards the potential of beta-end to regulate T-cell function via different mechanisms.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Annu Rev Immunol. 1988;6:219-49 - PubMed
    1. Proc Natl Acad Sci U S A. 1985 Sep;82(17):5751-5 - PubMed
    1. Immunology. 1988 Sep;65(1):47-51 - PubMed
    1. Immunopharmacol Immunotoxicol. 1988;10(3):265-326 - PubMed
    1. Mol Pharmacol. 1988 Dec;34(6):744-54 - PubMed

LinkOut - more resources